Time

Topic

Faculty

7:30 - 8:30 AM

Continental Breakfast

8:00 - 9:00 AM

New Agents for Lymphomas: Which One's
Will Make It?

Fredrick Hagemeister, MD

8:00 - 9:00 AM

Aggressive Treatment of "Indolent"
Lymphoma - Then and Now

Peter McLaughlin, MD

8:00 - 9:00 AM

Lymphoma Patient Case Review

Fernando Cabanillas, MD

9:00 - 10:00 AM

The Best New Drugs for MDS & How to Use Them

Guillermo Garcia-Manero, MD

9:00 - 10:00 AM

Optimal Treatment for Patients with Myeloma

Robert Z. Orlowski, MD, PhD

9:00 - 10:00 AM

Multiple Myeloma Patient Case Review

Donna Weber, MD

10:00 - 11:00 AM

Leukemia/MDS - Incorporating New Therapies
into Everyday Practice

Hagop Kantarjian, MD

10:00 - 11:00 AM

AML - Patient Case Review

Stefan Faderl, MD

10:00 - 11:00 AM

ALL - Patient Case Review

Susan O'Brien, MD

11:00 AM - 7:30 PM

Exhibits

SESSION I: CHRONIC LYMPHOCYTIC LEUKEMIA

12:15 - 12:30 PM

Welcome & Introduction

Michael J. Keating, MB, BS

12:30 - 12:45 PM

Watch & Wait - Who and Why? Is Early Treatment Indicated?

Michael Hallek, MD

12:45 - 1:00 PM

Prognostic Factors - Directing Treatment Strategies

William Wierda, MD, PhD

1:00 - 1:15 PM

Chemoimmunotherapy - Transforming Treatment

Michael J. Keating, MB, BS

1:15 - 1:30 PM

New Monoclonal Antibodies - Which Ones?

Susan O'Brien, MD

1:30 - 1:45 PM

Transplants in CLL - Timing and Expectation?

John G. Gribben, MD, DSc

1:45 - 2:00 PM

Flavopiridol and Other CDK Inhibitors

John C. Byrd, MD

2:00 - 2:15 PM

Management of Elderly CLL - Who's Elderly?

Kanti R. Rai, MD

2:15 - 2:45 PM

Break

2:45 - 3:00 PM

Familial CLL - Who Should be Concerned?

Neil E. Kay, MD

3:00 - 3:15 PM

Genetics in CLL - A Major Revolution

Carlo M. Croce, MD

3:15 - 3:30 PM

Vaccines & Gene Therapy - A Now Reality

Thomas Kipps, MD, PhD

3:30 - 3:45 PM

T-Cell Transfer Therapy for Leukemia

Carl H. June, MD

3:45 - 4:15 PM

Patient Case Presentation / Audience Response System

Emili Montserrat, MD

4:15 PM

Adjourn

5:00 - 6:00 PM

Independent Satellite Symposium
The Next Generation of Monoclonal Antibodies in CLL and NHL
Sponsored by Physicians Education Resource; supported by an Educational Grant from GlaxoSmithKline

6:00 - 7:30 PM

Poster Viewing & Welcome Reception

6:30 - 8:30 AM

Continental Breakfast

7:00 - 8:00 AM

Independent Satellite Symposium
Chemotherapy Advances in the Treatment of Chronic Lymphocytic Leukemia
Sponsored by Educational Concepts Group; supported by an Educational Grant from Cephalon

8:00 AM - 6:00 PM

Exhibits

SESSION II: ACUTE LYMPHOCYTIC LEUKEMIA

8:00 - 8:15 AM

Toward the Cure of Childhood ALL

Ching-Hon Pui, MD

8:15 - 8:30 AM

Burkitt Leukemia - Can Prognosis Be Further Improved?

Wendy Stock, MD

8:30 - 8:45 AM

Targeting Notch1 in T-ALL

8:45 - 9:00 AM

Transplants - Grounds for Optimism

Anthony Goldstone, FRCR (M)

9:00 - 9:15 AM

Ph Positive ALL - Which TKI? Do We Need
allo-SCT?

Deborah Thomas, MD

9:15 - 9:30 AM

ALL in the Adolescents and Young Adults:
What have we learned?

Sima Jeha, MD

9:30 - 10:00 AM

Break

10:00 - 10:15 AM

T-cell Lymphoblastic Lymphoma and T-cell
ALL - A Separate Entity?

Dieter Hoelzer, MD, PhD

10:15 - 10:30 AM

What Molecules Influence T-cell Disease?

A. Thomas Look, MD

10:30 - 10:45 AM

Discussion/Q & A

SESSION III: RARE LEUKEMIAS

11:00 - 11:15 AM

Large Granular Lymphocytosis — A Persistent Problem

Thomas P. Loughran, Jr., MD

11:30 - 11:45 AM

New Agents in T-cell Disease

Varsha Gandhi, PhD

11:45 - 12:00 PM

Hairy Cell Leukemia - Are We Done with It?

Farhad Ravandi, MD

12:00 - 12:30 PM

Adjourn and Lunch

12:30 - 1:30 PM

Independent Satellite Symposium
The Shifting Paradigm in the Treatment of Hematologic Malignancies and Disorders
Sponsored by Educational Concepts Group; supported by an Educational Grant from Celgene

SESSION IV: CHRONIC MYELOGENOUS LEUKEMIA

2:00 - 2:15 PM

Tyrosine Kinase Inhibitors - Old & New

Jorge Cortes, MD

2:30 - 2:45 PM

Bcr-Abl Mutations - Identification & Clinical Importance

Moshe Talpaz, MD

2:45 - 3:00 PM

Prevention and Management of Blast Crisis

Neil P. Shah, MD PhD

3:00 - 3:30 PM

Break

3:30 - 3:45 PM

Current Role of Allogeneic Transplant in CML

Richard Champlin, MD

3:45 - 4:00 PM

Stem Cells in CML - Identification and
Research Potential

Michael Deininger, MD, PhD

4:00 - 4:15 PM

Aurora Kinase Inhibitors - An Expanding Role

Elias Jabbour, MD

4:15 - 4:30 PM

Vaccines - Now or Ever?

David A. Scheinberg, MD, PhD

4:45 PM

Adjourn

6:30 - 9:00 PM

Faculty Dinner

6:30 - 8:30 AM

Continental Breakfast

7:00 - 8:00 AM

Independent Satellite Symposium
Successfully Treating Every AML Patient
Sponsored by Educational Concepts Group; supported by an Educational Grant from Cyclacel

8:00 AM - 4:00 PM

Exhibits

SESSION V: ACUTE MYELOGENOUS LEUKEMIA/MDS

8:00 - 8:15 AM

Where Does MDS Finish and AML Start?

Stephen D. Nimer, MD

8:30 - 8:45 AM

Lenalidomide - A Transforming Therapeutic Agent

Alan F. List, MD

9:00 - 9:15 AM

Can We Make Transplants Better and Safer?

Sergio Giralt, MD

9:15 - 9:30 AM

Can We Get More Out of Cytogenetics?

Detlaf Haase, MD, PhD

9:30 - 9:45 AM

What is the End Point of Therapy?

Judith E. Karp, MD

9:45 - 10:15 AM

Break

10:15 - 10:30 AM

Can We Cure APL Without Chemotherapy?

Elihu Estey, MD

10:30 - 10:45 AM

Can We Quantitate Minimum Residual Disease?

Dario Campana

10:45 - 11:00 AM

Gene Methylation and Acetylations- Clinical
and Therapeutic Relevance

Jean-Pierre Issa, MD

11:00 - 11:15 AM

Regulation of Hematopoietic Stem Cells

Margaret A. "Peggy" Goodell, PhD

11:15 - 11:30 AM

Getting the Iron Out

Luca Malcovati, MD

11:30 - 11:45 AM

Discussion/Q & A

12:00 - 12:30 PM

Adjourn and Lunch

12:30 - 1:30 PM

SESSION VI: BIOLOGY OF LEUKEMIA

2:00 - 2:15 PM

Genetics and Epigenetics - A New Level of Complexity

James Downing, MD

2:30 - 2:45 PM

MicroRNA Genes - Are They Druggable Targets?

George Calin, MD, PhD

3:00 - 3:15 PM

Zeev Estrov, MD

SESSION VII: MYELOPROLIFERATIVE DISORDERS

3:30 - 3:45 PM

WHO Classification - Order Out of Chaos

Ayalew Tefferi, MD

4:00 - 4:15 PM

JAK2 Inhibitors - A Reality? A Hope?

Srdan Verstovsek, MD

SESSION VIII: SUPPORTIVE CARE

4:15 - 4:30 PM

New Thrombopoietic Growth Factors

David Kuter, MD, PhD

4:45 - 5:00 PM

New and Better Antibiotics - How Do We Use Them?

Ken Rolston, MD